Williams Jones & Associates’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $112K | Sell |
101,661
-450
| -0.4% | -$496 | ﹤0.01% | 381 |
|
|
2019
Q1 | $134K | Buy |
102,111
+21,371
| +26% | +$28K | ﹤0.01% | 389 |
|
|
2018
Q4 | $74K | Sell |
80,740
-11,546
| -13% | -$10.6K | ﹤0.01% | 377 |
|
|
2018
Q3 | $190K | Hold |
92,286
| – | – | ﹤0.01% | 415 |
|
|
2018
Q2 | $166K | Hold |
92,286
| – | – | ﹤0.01% | 416 |
|
|
2018
Q1 | $217K | Hold |
92,286
| – | – | 0.01% | 401 |
|
|
2017
Q4 | $174K | Hold |
92,286
| – | – | ﹤0.01% | 413 |
|
|
2017
Q3 | $229K | Hold |
92,286
| – | – | 0.01% | 386 |
|
|
2017
Q2 | $254K | Buy |
92,286
+11,762
| +15% | +$32.4K | 0.01% | 355 |
|
|
2017
Q1 | $243K | Buy |
80,524
+11,430
| +17% | +$34.5K | 0.01% | 360 |
|
|
2016
Q4 | $218K | Hold |
69,094
| – | – | 0.01% | 349 |
|
|
2016
Q3 | $236K | Hold |
69,094
| – | – | 0.01% | 346 |
|
|
2016
Q2 | $158K | Hold |
69,094
| – | – | ﹤0.01% | 363 |
|
|
2016
Q1 | $173K | Buy |
69,094
+391
| +0.6% | +$979 | 0.01% | 309 |
|
|
2015
Q4 | $227K | Hold |
68,703
| – | – | 0.01% | 304 |
|
|
2015
Q3 | $166K | Hold |
68,703
| – | – | 0.01% | 335 |
|
|
2015
Q2 | $201K | Buy |
68,703
+557
| +0.8% | +$1.63K | 0.01% | 352 |
|
|
2015
Q1 | $273K | Hold |
68,146
| – | – | 0.01% | 320 |
|
|
2014
Q4 | $205K | Buy |
68,146
+6,195
| +10% | +$18.6K | 0.01% | 350 |
|
|
2014
Q3 | $157K | Hold |
61,951
| – | – | 0.01% | 317 |
|
|
2014
Q2 | $153K | Hold |
61,951
| – | – | 0.01% | 328 |
|
|
2014
Q1 | $164K | Buy |
61,951
+30,976
| +100% | +$82K | ﹤0.01% | 346 |
|
|
2013
Q4 | $90K | Hold |
30,975
| – | – | ﹤0.01% | 326 |
|
|
2013
Q3 | $95K | Buy |
30,975
+6,195
| +25% | +$19K | ﹤0.01% | 327 |
|
|
2013
Q2 | $79K | Buy |
+24,780
| New | +$79K | ﹤0.01% | 330 |
|